5-(3-tert-butylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-(2-methylphenyl)-1,2,4-oxadiazole;3-(2-methylphenyl)-5-[3-phenyl-5-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;2-methyl-4-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)benzonitrile;5-(3-phenylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;3-phenyl-5-[3-phenyl-5-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)-5-(trifluoromethyl)benzonitrile
C128H95F9N20O9 — CID 158053300
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(3-tert-butylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-(2-methylphenyl)-1,2,4-oxadiazole;3-(2-methylphenyl)-5-[3-phenyl-5-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;2-methyl-4-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)benzonitrile;5-(3-phenylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;3-phenyl-5-[3-phenyl-5-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)-5-(trifluoromethyl)benzonitrile
5-(3-tert-butylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-(2-methylphenyl)-1,2,4-oxadiazole;3-(2-methylphenyl)-5-[3-phenyl-5-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;2-methyl-4-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)benzonitrile;5-(3-phenylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;3-phenyl-5-[3-phenyl-5-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)-5-(trifluoromethyl)benzonitrile (PubChem CID 158053300) has the molecular formula C128H95F9N20O9 and a molecular weight of 2228.28 g/mol. Its IUPAC name is 5-(3-tert-butylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-(2-methylphenyl)-1,2,4-oxadiazole;3-(2-methylphenyl)-5-[3-phenyl-5-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;2-methyl-4-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)benzonitrile;5-(3-phenylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;3-phenyl-5-[3-phenyl-5-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)-5-(trifluoromethyl)benzonitrile.
Molecular Properties
| Compound Name | 5-(3-tert-butylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-(2-methylphenyl)-1,2,4-oxadiazole;3-(2-methylphenyl)-5-[3-phenyl-5-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;2-methyl-4-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)benzonitrile;5-(3-phenylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;3-phenyl-5-[3-phenyl-5-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)-5-(trifluoromethyl)benzonitrile |
|---|---|
| PubChem CID | 158053300 |
| Molecular Formula | C128H95F9N20O9 |
| Molecular Weight | 2228.28 g/mol |
| Exact Mass | 2226.74 |
| IUPAC Name | 5-(3-tert-butylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-(2-methylphenyl)-1,2,4-oxadiazole;3-(2-methylphenyl)-5-[3-phenyl-5-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;2-methyl-4-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)benzonitrile;5-(3-phenylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;3-phenyl-5-[3-phenyl-5-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)-5-(trifluoromethyl)benzonitrile |
| SMILES | CC(C)(C)c1cccc(-c2nc(-c3ccncc3)no2)c1.CCOc1ccc(-c2nc(-c3ccccc3C)no2)cc1OCC.Cc1cc(-c2nc(-c3ccncc3)no2)ccc1C#N.Cc1ccccc1-c1noc(-c2cc(-c3ccccc3)cc(C(F)(F)F)c2)n1.FC(F)(F)c1cc(-c2ccccc2)cc(-c2nc(-c3ccccc3)no2)c1.N#Cc1cc(-c2nc(-c3ccncc3)no2)cc(C(F)(F)F)c1.c1ccc(-c2cccc(-c3nc(-c4ccncc4)no3)c2)cc1 |
| InChI | InChI=1S/C22H15F3N2O.C21H13F3N2O.C19H13N3O.C19H20N2O3.C17H17N3O.C15H7F3N4O.C15H10N4O/c1-14-7-5-6-10-19(14)20-26-21(28-27-20)17-11-16(15-8-3-2-4-9-15)12-18(13-17)22(23,24)25;22-21(23,24)18-12-16(14-7-3-1-4-8-14)11-17(13-18)20-25-19(26-27-20)15-9-5-2-6-10-15;1-2-5-14(6-3-1)16-7-4-8-17(13-16)19-21-18(22-23-19)15-9-11-20-12-10-15;1-4-22-16-11-10-14(12-17(16)23-5-2)19-20-18(21-24-19)15-9-7-6-8-13(15)3;1-17(2,3)14-6-4-5-13(11-14)16-19-15(20-21-16)12-7-9-18-10-8-12;16-15(17,18)12-6-9(8-19)5-11(7-12)14-21-13(22-23-14)10-1-3-20-4-2-10;1-10-8-12(2-3-13(10)9-16)15-18-14(19-20-15)11-4-6-17-7-5-11/h2-13H,1H3;1-13H;1-13H;6-12H,4-5H2,1-3H3;4-11H,1-3H3;1-7H;2-8H,1H3 |
| InChIKey | FJSYFVNBUUXADE-UHFFFAOYSA-N |
| XLogP | 32.23 |
| TPSA | 390.04 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 29 |
| Rotatable Bonds | 21 |
| Heavy Atoms | 166 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2228.28 |
| LogP ≤ 5 | 32.23 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 29 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158053300 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.